# Long-Term Cardiovascular and Metabolic Health Outcomes of Gestational Diabetes Mellitus: A Systematic Review

**Authors:** Inayat Ullah, Samad Ali Khan, Dure Nayab, Sohail Ahmad, Asmad Khan, Nughman Ali, Jamil Ahmad, Zeeshan Ali, Sundas Safdar, Muhammad Imran Khan

PMC · DOI: 10.7759/cureus.79555 · 2025-02-24

## TL;DR

Gestational diabetes mellitus increases long-term health risks for mothers and their children, including diabetes and heart disease, highlighting the need for early detection and personalized care.

## Contribution

This systematic review provides updated evidence on the long-term cardiovascular and metabolic impacts of GDM and identifies potential strategies for risk reduction.

## Key findings

- Women with GDM have higher risks of type 2 diabetes, hypertension, and metabolic syndrome.
- Children of mothers with GDM face increased risks of obesity, insulin resistance, and cardiovascular disease.
- Early detection and interventions like probiotics and lactation may help reduce maternal GDM risks.

## Abstract

The public health concern associated with gestational diabetes mellitus (GDM) generates serious cardiovascular and metabolic impacts that affect both mothers whose condition went undiagnosed and their offspring. The review evaluates contemporary data about how GDM affects long-term health results. We searched published studies from databases such as PubMed, Scopus, and the Cochrane Library. A total of 710 records were identified, with 173 duplicates and 61 irrelevant records removed, leaving 476 for screening. After excluding 282, 194 reports were sought for retrieval, 97 were not retrieved, 97 were assessed for eligibility, 85 were excluded, and 12 studies were included in the review. Women with GDM face higher risks of type 2 diabetes (HR 2.5-7.1), hypertension (HR 3.2), and metabolic syndrome (HR 4.1). Their offspring have increased risks of obesity (OR 2.9), insulin resistance, cardiovascular disease, and metabolic disorders from childhood to adolescence. This review examines early detection biomarkers alongside strategies like lactation, probiotics, and CRP levels to potentially reduce maternal GDM risks. Although research had some methodological limitations regarding diagnostic irregularities and variable follow-up durations the findings demonstrate that early identification of GDM matters alongside customized care plans and long-term monitoring of women's health status. The review offers vital clinical guidelines and research pathways for advancing maternal and child health practices.

## Linked entities

- **Diseases:** gestational diabetes mellitus (MONDO:0005406), type 2 diabetes (MONDO:0005148), metabolic syndrome (MONDO:0000816), obesity (MONDO:0011122), cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** metabolic syndrome (MESH:D024821), insulin resistance (MESH:D007333), type 2 diabetes (MESH:D003924), obesity (MESH:D009765), hypertension (MESH:D006973), cardiovascular disease (MESH:D002318), GDM (MESH:D016640), metabolic disorders (MESH:D008659)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11938991/full.md

---
Source: https://tomesphere.com/paper/PMC11938991